Aligos Therapeutics (ALGS) Return on Sales [ROS] (2019 - 2026)
Aligos Therapeutics (ALGS) posted Return on Sales [ROS] of -2112.14% for Q2 2026, down 188.10 percentage points from -1924.04% a year earlier and down 1160.58 percentage points from the prior quarter.
Powered by 
Analysis
Aligos Therapeutics (ALGS) Return on Sales [ROS] (2019 - 2026) Analysis & Trends
For FY2025, Aligos Therapeutics' Return on Sales [ROS] came in at -4024.93%, down 1555.98 percentage points from FY2024.
- Annual Return on Sales [ROS] has declined for three consecutive years, with a four-year change of -1081.11 percentage points (FY2021 to FY2025).
- In prior years, Aligos Therapeutics' Return on Sales [ROS] was -2468.96% in FY2024 (-1525.21 pp), -943.75% in FY2023 (-242.08 pp), -701.66% in FY2022 (+2242.16 pp) and -2943.82% in FY2021.
- Quarterly Return on Sales [ROS] has run from a low of -12907.69% in Q4 2025 to a high of -445.76% in Q2 2023 over five years.
- On a year-over-year basis, Return on Sales [ROS] increased in two of the last eight quarters, with an average year-over-year change of -1494.15 percentage points.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q4 2022, with a gain of 9698.78 percentage points; the weakest was Q4 2025, with a drop of 9514.46 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -951.55% (Q1 2026), -12907.69% (Q4 2025) and -3827.40% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 28.37% |
| 10 | Aligos Therapeutics | 50.07 Mn | -278.34 Mn | - | -2,112.14% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,112.14% |
| Mar 31, 2026 | -951.55% |
| Dec 31, 2025 | -12,907.69% |
| Sep 30, 2025 | -3,827.40% |
| Jun 30, 2025 | -1,924.04% |
| Mar 31, 2025 | -6,187.46% |
| Dec 31, 2024 | -3,393.23% |
| Sep 30, 2024 | -1,610.48% |
| Jun 30, 2024 | -2,489.54% |
| Mar 31, 2024 | -3,176.66% |
| Dec 31, 2023 | -1,294.03% |
| Sep 30, 2023 | -885.38% |
| Jun 30, 2023 | -445.76% |
| Mar 31, 2023 | -925.98% |
| Dec 31, 2022 | -641.28% |
| Sep 30, 2022 | -461.47% |
| Jun 30, 2022 | -552.21% |
| Mar 31, 2022 | -1,383.00% |
| Dec 31, 2021 | -10,340.05% |
| Sep 30, 2021 | -2,151.46% |
API Access
Aligos Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ALGS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();